ClinicalTrials.govpublic full text
CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
malignant glioma, glioblastoma, brain cancer, gliosarcoma, cell therapy, gene therapy, immunotherapy, glioma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 870470
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.